Par Pharmaceutical Recalls Everolimus Tablets Due to Impurity Risk
Par Pharmaceutical recalled 1,041 cartons of Everolimus tablets on September 5, 2025. The recall stems from failed impurities and degradation specifications. Consumers should stop using the product immediately.